Last reviewed · How we verify

NCT06572098

The Effect of Complex Decongestıve Therapy on Oxıdatıve Stress and Antıoxıdants

ENROLLING BY INVITATION NA Last updated 24 September 2024
What this trial tests

NA trial testing Complex decongestive therapy in What Are the Effects of Lymphedema Treatment in 52 participants. Enrolling by invitation.

Timeline
3 April 2024
Primary endpoint
3 April 2027
3 April 2028

Quick facts

Lead sponsorBaskent University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment52
Start date3 April 2024
Primary completion3 April 2027
Estimated completion3 April 2028
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Baskent University

Who can join

25 and older, female only, with What Are the Effects of Lymphedema Treatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is aimed to determine the changes of complex decongestive therapy applications on oxidative stress parameters and antioxidants in patients with lymphedema after breast cancer treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Complex decongestive therapy

Trials testing the same drug.

Other Baskent University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06572098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing